SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012564
Filing Date
2023-07-31
Accepted
2023-07-31 16:15:47
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20230630x10q.htm   iXBRL 10-Q 1289834
2 EX-3.2 imgn-20230630xex3d2.htm EX-3.2 154546
3 EX-10.1 imgn-20230630xex10d1.htm EX-10.1 31790
4 EX-31.1 imgn-20230630xex31d1.htm EX-31.1 10919
5 EX-31.2 imgn-20230630xex31d2.htm EX-31.2 11005
6 EX-32 imgn-20230630xex32.htm EX-32 10059
  Complete submission text file 0001558370-23-012564.txt   6852470

Data Files

Seq Description Document Type Size
7 EX-101.SCH imgn-20230630.xsd EX-101.SCH 60534
8 EX-101.CAL imgn-20230630_cal.xml EX-101.CAL 38155
9 EX-101.DEF imgn-20230630_def.xml EX-101.DEF 273982
10 EX-101.LAB imgn-20230630_lab.xml EX-101.LAB 472936
11 EX-101.PRE imgn-20230630_pre.xml EX-101.PRE 415015
72 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20230630x10q_htm.xml XML 900514
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 231127595
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences